A logo

Agilent Technologies (A)

Profile

Full Name

Agilent Technologies, Inc.

Ticker Symbol

A

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

November 18, 1999

Indexes

S&P 500

Website

http://www.agilent.com

Employees

17900

Key Details

Price

$102.71(+2.76%)

Market cap

Last Dividend

$0.25

TTM Dividend yield

0.94%

Annual revenue

$6.51B(-4.73% YoY)

Annual EPS

$4.43(+5.73% YoY)

PE ratio

23.61

Next earnings date

May 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$102.71
A price is $102.71

30-Day Relative Volume

1.09
A 30-day relative volume is 1.09

Price Performance

Price Most recent change

+2.76%
A price was up +2.76% on Apr 11, 2025

Price YTD change

-23.54%
A price is down -23.54% since January 1st

Price 1-year change

-29.17%
A price is down -29.17% year-on-year

Price 3-year change

-21.75%
A price is down -21.75% over the past 3 years

Price Range

Price All-time high

$179.57
A price is currently -42.80% below its historical high of $179.57

Price 3-year low

$96.43
A price is currently +6.51% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$29.28B
A market capitalization is $29.28 billion

Market cap 3-year change

-25.66%
A market capitalization is down -25.66% over the past 3 years

Market cap All-time high

$54.27B
A market capitalization is currently -46.04% below its historical high of $54.27 billion

Market cap sector rank

96.55%
A market capitalization is higher than 96.55% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-2.71%
A shares outstanding is down -2.71% year-on-year

Shares Outstanding 3-Year Change

-5%
A shares outstanding is down -5% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.89
A beta is 0.89

200-day SMA

$134.83
A price is currently -23.82% below its 200-day simple moving average

50-day SMA

$125.91
A price is currently -18.43% below its 50-day simple moving average

RSI

34.09
A 14-day relative strength index is 34.09

Volume

1.09
A 30-day relative volume is 1.09

ATR

$5.29
A average true range is $5.29

10-day Historical Volatility

73.40%
A 10-day historical volatility is 73.40%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.25
A last dividend was $0.25 per share, with an ex-dividend date of April 1, 2025

Next Dividend

-
A next dividend has not yet been announced

Dividend per share

Dividend per share

$0.94
A annual dividend per share is $0.94

Dividend per share Sector Rank

38.37%
A annual dividend per share is higher than 38.37% of companies in Healthcare sector

Dividend per share 1-Year Change

+4.89%
A annual dividend per share is up +4.89% year-on-year

Dividend per share 3-Year Change

+21.65%
A annual dividend per share is up +21.65% over the past 3 years

Dividend yield

Dividend yield

0.92%
A annual dividend yield is 0.92%

Dividend yield Sector Rank

28.24%
A annual dividend yield is higher than 28.24% of companies in Healthcare sector

Other

Payout ratio

21.26%
A annual payout ratio is 21.26%

Dividends paid

$274.00M
A annual dividends paid is $274.00 million

Free cash flow

$1.37B
A annual free cash flow is $1.37 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$6.51B
A annual revenue is $6.51 billion

Revenue Analysts estimate

$6.74B
A annual revenue is currently -3.37% lower than the consensus analysts' forecast

Revenue 1-year change

-4.73%
A annual revenue is down -4.73% year-on-year

Revenue Sector rank

92.83%
A annual revenue is higher than 92.83% of companies in Healthcare sector

EPS

EPS

$4.43
A annual earnings per share is $4.43

EPS Analysts estimate

$5.56
A annual earnings per share is currently -20.39% lower than the consensus analysts' forecast

EPS 1-year change

+5.73%
A annual earnings per share is up +5.73% year-on-year

EPS Sector rank

95.46%
A annual earnings per share is higher than 95.46% of companies in Healthcare sector

Profit

Gross profit

$3.54B
A annual gross profit is $3.54 billion

Gross margin

54.30%
A annual gross profit margin is 54.30%

Operating profit

$1.49B
A annual operating income is $1.49 billion

Operating margin

22.86%
A annual operating profit margin is 22.86%

Net income

$1.29B
A annual net profit is $1.29 billion

Net margin

19.80%
A annual net profit margin is 19.80%

Expenses

Total expenses

$5.02B
A annual total expenses is $5.02 billion

Operating expenses

$2.05B
A annual total operating expenses is $2.05 billion

Cost of goods sold

$2.98B
A annual cost of goods sold is $2.98 billion

Selling, general & administrative expenses

$1.57B
A annual SGA is $1.57 billion

Depreciation and amortization

$257.00M
A annual depreciation & amortization is $257.00 million

Interest expense

$96.00M
A annual interest expense is $96.00 million

Income tax

$232.00M
A annual income tax is $232.00 million

EBIT & EBITDA

EBIT

$1.62B
A annual earnings before interest & taxes is $1.62 billion

EBITDA

$1.87B
A annual EBITDA is $1.87 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$11.85B
A annual total assets is $11.85 billion

Non current assets

$7.89B
A annual long term assets is $7.89 billion

Current assets

$3.96B
A annual total current assets is $3.96 billion

Cash and cash equivalents

$1.33B
A annual cash & cash equivalents is $1.33 billion

Accounts receivable

$1.32B
A annual accounts receivable is $1.32 billion

Inventory

$972.00M
A annual inventory is $972.00 million

Liabilities

Total liabilities

$5.95B
A annual total liabilities is $5.95 billion

Long term liabilities

$4.05B
A annual total long term liabilities is $4.05 billion

Current liabilities

$1.90B
A annual total current liabilities is $1.90 billion

Accounts payable

$540.00M
A annual accounts payable is $540.00 million

Debt

Total debt

$3.39B
A annual total debt is $3.39 billion

Total debt 1-year change

+23.95%
A annual total debt is up +23.95% year-on-year

Long term debt

$3.35B
A annual long term debt is $3.35 billion

Short term debt

$45.00M
A annual short term debt is $45.00 million

Equity & Capital

Shareholders equity

$5.90B
A annual stockholders equity is $5.90 billion

Book value

$5.90B
A annual book value is $5.90 billion

Retained earnings

$750.00M
A annual retained earnings is $750.00 million

Working capital

$2.06B
A annual working capital is $2.06 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.75B
A annual cash flow from operations is $1.75 billion

Cash from operations 1-year change

-1.19%
A annual cash flow from operations is down -1.19% year-on-year

Cash from investing

-$1.26B
A annual cash flow from investing activities is -$1.26 billion

Cash from investing 1-year change

-305.81%
A annual cash flow from investing activities is down -305.81% year-on-year

Cash from financing

-$752.00M
A annual cash flow from financing activities is -$752.00 million

Cash from financing 1-year change

+19.14%
A annual cash flow from financing activities is up +19.14% year-on-year

CAPEX

CAPEX

$378.00M
A annual capital expenditures is $378.00 million

CAPEX 1-year change

+26.85%
A annual capital expenditures is up +26.85% year-on-year

Free Cash Flow

Free cash flow

$1.37B
A annual free cash flow is $1.37 billion

Free cash flow 1-year change

-6.85%
A annual free cash flow is down -6.85% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

54.30%
A annual gross profit margin is 54.30%

Operating margin

22.86%
A annual operating profit margin is 22.86%

Net margin

19.80%
A annual net profit margin is 19.80%

ROA & ROE

ROA

11.40%
A annual return on assets is 11.40%

ROE

21.95%
A annual return on equity is 21.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

23.61
A price to earnings ratio is 23.61

PE ratio Sector rank

46.57%
A price to earnings ratio is higher than 46.57% of companies in Healthcare sector

PB Ratio

PB ratio

4.86
A price to book ratio is 4.86

PB ratio Sector rank

82.89%
A price to book ratio is higher than 82.89% of companies in Healthcare sector

PS Ratio

PS ratio

4.48
A price to sales ratio is 4.48

PS ratio Sector rank

64.62%
A price to sales ratio is higher than 64.62% of companies in Healthcare sector

Enterprise value

Enterprise value

$31.18B
A enterprise value is $31.18 billion

Enterprise value Sector rank

96.46%
A enterprise value is higher than 96.46% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

16.82
A EV/EBITDA is 16.82

EV/EBITDA Sector rank

89.67%
A EV/EBITDA is higher than 89.67% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.09
A annual current ratio is 2.09

Quick ratio

1.58
A annual quick ratio is 1.58

Leverage

Debt to equity

0.57
A annual debt to equity ratio is 0.57

Interest coverage ratio

16.84
A annual interest coverage ratio is 16.84

Risk & Stability

Piotroski F-Score

5
A piotroski f-score is 5

Altman Z-Score

4.25
A altman z-score is 4.25

Analyst ratings

Recent major analysts updates

Apr 10, 25 Barclays
Equal-Weight
Feb 27, 25 Baird
Outperform
Feb 10, 25 Barclays
Equal-Weight
Jan 27, 25 B of A Securities
Neutral
Jan 10, 25 Bernstein
Market Perform
Dec 13, 24 B of A Securities
Neutral
Dec 9, 24 Wells Fargo
Overweight
Nov 27, 24 Barclays
Underweight
Nov 26, 24 JP Morgan
Overweight
Nov 26, 24 Evercore ISI Group
In-Line

Institutional Ownership

Similar stocks

GEHC logo
GE HealthCare Technologies (GEHC)
ALNY logo
Alnylam Pharmaceuticals (ALNY)
RMD logo
ResMed (RMD)
CNC logo
Centene (CNC)
IDXX logo
IDEXX Laboratories (IDXX)
CAH logo
Cardinal Health (CAH)
DXCM logo
DexCom (DXCM)
IQV logo
IQVIA Holdings (IQV)
BeiGene (ONC)
  • What is the ticker symbol for Agilent Technologies?
  • Does Agilent Technologies pay dividends?
  • What sector is Agilent Technologies in?
  • What industry is Agilent Technologies in?
  • What country is Agilent Technologies based in?
  • When did Agilent Technologies go public?
  • Is Agilent Technologies in the S&P 500?
  • Is Agilent Technologies in the NASDAQ 100?
  • Is Agilent Technologies in the Dow Jones?
  • When was Agilent Technologies's last earnings report?
  • When does Agilent Technologies report earnings?
  • Should I buy Agilent Technologies stock now?

What is the ticker symbol for Agilent Technologies?

The ticker symbol for Agilent Technologies is NYSE:A

Does Agilent Technologies pay dividends?

Yes, Agilent Technologies pays dividends. The last payment was $0.25, with an ex-dividend date on April 1, 2025

What sector is Agilent Technologies in?

Agilent Technologies is in the Healthcare sector

What industry is Agilent Technologies in?

Agilent Technologies is in the Diagnostics & Research industry

What country is Agilent Technologies based in?

Agilent Technologies is headquartered in United States

When did Agilent Technologies go public?

Agilent Technologies's initial public offering (IPO) was on November 18, 1999

Is Agilent Technologies in the S&P 500?

Yes, Agilent Technologies is included in the S&P 500 index

Is Agilent Technologies in the NASDAQ 100?

No, Agilent Technologies is not included in the NASDAQ 100 index

Is Agilent Technologies in the Dow Jones?

No, Agilent Technologies is not included in the Dow Jones index

When was Agilent Technologies's last earnings report?

Agilent Technologies's most recent earnings report was on Feb 26, 2025

When does Agilent Technologies report earnings?

The next expected earnings date for Agilent Technologies is May 29, 2025

Should I buy Agilent Technologies stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page